, Volume 36, Issue 3, pp 234–238 | Cite as

HLA-associated susceptibility to Type 2 (non-insulin-dependent) diabetes mellitus: the Wadena City Health Study

  • S. S. Rich
  • L. R. French
  • J. M. Sprafka
  • J. P. Clements
  • F. C. Goetz


Epidemiologic data suggest that a parental history of Type 2 (non-insulin-dependent) diabetes mellitus increases the risk of Type 1 (insulin-dependent) diabetes in siblings of a Type 1 diabetes proband. This increase in risk is consistent with a shared genetic susceptibility between Type 1 and Type 2 diabetes. We have previously reported evidence that HLA-DR4-linked factors may represent a homogeneous subset of diabetes susceptibility. First, HLA-DR4 frequency was higher in Type 1 diabetic study subjects with a Type 2 diabetic parent than in Type 1 diabetic subjects whose parents were not diabetic. Second, a DR4-haplotype was transmitted from the Type 2 diabetic parent to the Type 1 offspring more often than expected. These data are consistent with the hypothesis that families with a Type 2 diabetic parent and Type 1 diabetic child, heavily determined by HLA-DR4 linked factors, may represent a homogeneous subset of diabetes susceptibility. In this report, we further explore the relationship between the high-risk HLA antigen (HLA-DR4) in study subjects with differing glycaemic status (National Diabetes Data Group criteria). In this community-based study, we find evidence that HLA-DR4 is increased in study subjects with Type 2 diabetes and may be a marker for Type 2 diabetes susceptibility.

Key words

Genetics Type 2 (non-insulin-dependent) diabetes mellitus HLA 


  1. 1.
    Newman B, Selby JV, King MC, Slemenda C, Fabsitz R, Friedman GD (1987) Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 30: 763–768CrossRefPubMedGoogle Scholar
  2. 2.
    Chern MM, Anderson VE, Barbosa J (1982) Empirical risk for insulin-dependent diabetes (IDD) in sibs. Further definition of genetic heterogeneity. Diabetes 31: 1115–1118PubMedGoogle Scholar
  3. 3.
    Wagener DK, Sacks JM, LaPorte RE, Macgregor JM (1982) The Pittsburgh study of insulin-dependent diabetes mellitus. Risk for diabetes among relatives of IDDM. Diabetes 31: 136–144PubMedGoogle Scholar
  4. 4.
    Rich SS, Panter SS, Goetz FC, Hedlund B, Barbosa J (1991) Shared genetic susceptibility of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus: contributions of HLA and haptoglobin. Diabetologia 34: 350–355PubMedGoogle Scholar
  5. 5.
    French LR, Boen JR, Martinez AM, Bushhouse SA, Sprafka JM, Goetz FC (1990) A population-based study of impaired glucose tolerance and type II diabetes: the Wadena City Health Study. Diabetes 39: 1131–1137PubMedGoogle Scholar
  6. 6.
    Harris MI, Hadden WC, Knowler WC, Bennett PH (1987) Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20–74 yr. Diabetes 36: 523–534PubMedGoogle Scholar
  7. 7.
    National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039–1057PubMedGoogle Scholar
  8. 8.
    Barbosa J, Bach FH, Rich SS (1982) Genetic heterogeneity of diabetes and HLA. Clin Genet 21: 25–32PubMedGoogle Scholar
  9. 9.
    Harris MI, Entmacher P (1985) Classification and diagnostic criteria for diabetes and other categories of glucose intolerance. In: Harris M, Hamman RF (eds) Diabetes in America. U.S. Government Printing Office. Washington, D. C., Chap. 2Google Scholar
  10. 10.
    DCCT Research Group (1987) Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). J Clin Endocrinol Metab 65: 30–36Google Scholar
  11. 11.
    Fleiss JL (1981) Statistical methods for rates and proportions. Wiley, New YorkGoogle Scholar
  12. 12.
    SPSS (1990) SPSS-X Users guide. 3rd edn. SPSS, ChicagoGoogle Scholar
  13. 13.
    Nerup J, Platz P, Andersen OO et al. (1974) HL-A antigens and diabetes mellitus. Lancet II: 864–866CrossRefGoogle Scholar
  14. 14.
    Spielman RS, Baker L, Zmijewski CM (1980) Gene dosage and susceptibility to insulin-dependent diabetes. Ann Hum Gent 44: 135–150Google Scholar
  15. 15.
    Rich SS (1990) Mapping genes in diabetes: a genetic epidemiological perspective. Diabetes 39: 1315–1319PubMedGoogle Scholar
  16. 16.
    McMillan DE (1989) Increased levels of acute-phase serum proteins in diabetes. Metabolism 38: 1042–1046CrossRefPubMedGoogle Scholar
  17. 17.
    Groop L, Koskimies S, Pelkonen R, Tolppanen EM (1983) Increased frequency of HLA-Cw4 in type 2 diabetes. Acta Endocrinol (Copenh) 104: 475–478Google Scholar
  18. 18.
    Groop L, Miettinen A, Groop PH, Meri S, Koskimies S, Bottazzo GF (1988) Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes. Diabetes 37: 99–103PubMedGoogle Scholar
  19. 19.
    Chakraborty R, Ferrell RE, Stern MP, Haffner SM, Hazuda HP, Rosenthal M (1986) Relationship of prevalence of non-insulin-dependent diabetes mellitus to Amerindian admixture in the Mexican Americans of San Antonio, Texas. Genet Epidemiol 3: 435–454PubMedGoogle Scholar
  20. 20.
    Stern MP, Ferrell RE, Rosenthal M, Haffner SM, Hazuda HP (1986) Association between NIDDM, Rh blood group, and haptoglobin phenotype. Results from the San Antonio Heart Study. Diabetes 35: 387–391PubMedGoogle Scholar
  21. 21.
    Iyengar S, Hamman RF, Marshall JA, Baxter J, Majumder PP, Ferrell RE (1989) Genetic studies of type 2 (non-insulin-dependent) diabetes mellitus: lack of association with seven genetic markers. Diabetologia 32: 690–693CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • S. S. Rich
    • 1
  • L. R. French
    • 2
  • J. M. Sprafka
    • 3
  • J. P. Clements
    • 2
  • F. C. Goetz
    • 4
  1. 1.Department of Laboratory Medicine and Pathology and Institute of Human GeneticsUniversity of MinnesotaMinneapolisUSA
  2. 2.Chronic Disease and Environmental Epidemiology Section, Minnesota Department of HealthUniversity of MinnesotaMinneapolisUSA
  3. 3.Division of EpidemiologyUniversity of MinnesotaMinneapolisUSA
  4. 4.Department of MedicineUniversity of MinnesotaMinneapolisUSA

Personalised recommendations